7JZM

SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3)

Summary for 7JZM

Entry DOI	10.2210/pdb7jzm/pdb
EMDB information	22533
Descriptor	LCB3, Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total)
Functional Keywords	sars-cov-2, covid-19, spike glycoprotein, fusion protein, neutralizing antibodies, structural genomics, seattle structural genomics center for infectious disease, ssgcid, inhibitor, viral protein
Biological source	synthetic construct More
Total number of polymer chains	2
Total formula weight	154943.26
Authors	Park, Y.J.,Veesler, D.,Seattle Structural Genomics Center for Infectious Disease (SSGCID) (deposition date: 2020-09-02, release date: 2020-09-23, Last modification date: 2020-11-04)
Primary citation	Cao, L.,Goreshnik, I.,Coventry, B.,Case, J.B.,Miller, L.,Kozodoy, L.,Chen, R.E.,Carter, L.,Walls, A.C.,Park, Y.J.,Strauch, E.M.,Stewart, L.,Diamond, M.S.,Veesler, D.,Baker, D. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science, 370:426-431, 2020 Cited by PubMed: 32907861 DOI: 10.1126/science.abd9909 PDB entries with the same primary citation
Experimental method	ELECTRON MICROSCOPY (3.5 Å)

Structure validation